Biological: LV009 injection
PG-012-10
Phase 1 small_molecule active
Quick answer
Biological: LV009 injection for CD19+ Relapse/Refractory B-ALL is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- CD19+ Relapse/Refractory B-ALL
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active